A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Tenamfetamine
The risk or severity of serotonin syndrome can be increased when Tenamfetamine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Etorphine
The risk or severity of serotonin syndrome can be increased when Etorphine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Dimethyltryptamine
The risk or severity of serotonin syndrome can be increased when Dimethyltryptamine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of serotonin syndrome can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Ethylmorphine
The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Alaproclate
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Alaproclate.
2,5-Dimethoxyamphetamine
Ritanserin
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Ritanserin.
2,5-Dimethoxyamphetamine
Indalpine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Indalpine.
2,5-Dimethoxyamphetamine
Desvenlafaxine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Desvenlafaxine.
2,5-Dimethoxyamphetamine
Milnacipran
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Milnacipran.
2,5-Dimethoxyamphetamine
Dapoxetine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Dapoxetine.
2,5-Dimethoxyamphetamine
Rotigotine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Rotigotine.
2,5-Dimethoxyamphetamine
Remimazolam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Remimazolam.
2,5-Dimethoxyamphetamine
Bromperidol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Bromperidol.
2,5-Dimethoxyamphetamine
Mephenesin
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Mephenesin.
2,5-Dimethoxyamphetamine
Ethyl chloride
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Ethyl chloride.
2,5-Dimethoxyamphetamine
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Carfentanil, C-11.
2,5-Dimethoxyamphetamine
JNJ-26489112
The risk or severity of adverse effects can be increased when Lasmiditan is combined with JNJ-26489112.
2,5-Dimethoxyamphetamine
Solriamfetol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Solriamfetol.
2,5-Dimethoxyamphetamine
Bentazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Bentazepam.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3